title: Risky business: challenges in vaccine risk communication.
authors.affiliation: Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, Maryland 20852, USA.
authors.forename: L K
authors.initials: LK
authors.lastname: Ball
authors.forename: G
authors.initials: G
authors.lastname: Evans
authors.forename: A
authors.initials: A
authors.lastname: Bostrom
mesh_terms: D001294:Attitude to Health; D002648:Child; D003142:Communication; D049673:History, 20th Century; D006801:Humans; D010344:Patient Advocacy; D010567:Pertussis Vaccine / Q000009:adverse effects / Q000266:history; D018570:Risk Assessment; D014611:Vaccination / Q000009:adverse effects / Q000266:history / Q000331:legislation & jurisprudence; D014612:Vaccines / Q000009:adverse effects* / Q000266:history
chemical_list: D010567:Pertussis Vaccine; D014612:Vaccines